• wegovy
    ,

    Wegovy

    Wegovy (semaglutide) is a once‑weekly injectable for chronic weight management that helps reduce body weight and improve metabolic markers; learn dosing, benefits, safety, and patient tips.

    Price range: $170.00 through $730.00
    Select options This product has multiple variants. The options may be chosen on the product page
  • Saxenda
    ,

    Saxenda

    Saxenda is the brand name for liraglutide, a glucagon‑like peptide‑1 (GLP‑1) receptor agonist approved for chronic weight management. It is administered as a once‑daily subcutaneous injection and carries a boxed warning about potential thyroid C‑cell tumors; it is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Saxenda has been approved for adult obesity treatment and for certain adolescent patients, and the official prescribing information provides detailed dosing and safety guidance.

    Price range: $92.57 through $268.00
    Select options This product has multiple variants. The options may be chosen on the product page
  • ozempic
    ,

    Ozempic

    Ozempic (semaglutide) is a once‑weekly injectable GLP‑1 receptor agonist for adults with type 2 diabetes that lowers HbA1c, supports weight loss, and carries a boxed warning about potential thyroid C‑cell tumors.

    Price range: $95.00 through $210.00
    Select options This product has multiple variants. The options may be chosen on the product page
  • Mounjaro

    Mounjaro

    Mounjaro (tirzepatide) is a once‑weekly injectable for type 2 diabetes that improves blood sugar and supports weight loss. Learn dosing, benefits, safety, side effects, and patient tips.

    Price range: $220.00 through $430.00
    Select options This product has multiple variants. The options may be chosen on the product page
  • Victoza
    ,

    Victoza

    Victoza is the brand name for liraglutide, a once‑daily, non‑insulin injectable medication used with diet and exercise to improve glycemic control in adults and children 10 years and older with type 2 diabetes.

    Price range: $540.00 through $815.00
    Select options This product has multiple variants. The options may be chosen on the product page
  • Trulicity
    ,

    Trulicity

    Trulicity is the brand name for dulaglutide, a once‑weekly injectable glucagon‑like peptide‑1 (GLP‑1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Trulicity also has indications related to reducing major adverse cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease or multiple risk factors.

    Price range: $175.00 through $215.00
    Select options This product has multiple variants. The options may be chosen on the product page
  • Byetta dosage
    ,

    Byetta

    Byetta (exenatide) is a twice‑daily injectable GLP‑1 receptor agonist for adults with type 2 diabetes that lowers post‑meal blood sugar and may support modest weight loss; it requires careful use in people with kidney or severe gastrointestinal disease.

    Price range: $310.00 through $600.00
    Select options This product has multiple variants. The options may be chosen on the product page
  • Sale! Adlyxin

    Adlyxin

    Adlyxin/Lyxumia (generic name: lixisenatide) is a prescription medication used to help adults with type 2 diabetes manage blood sugar levels. It belongs to a class of drugs called GLP-1 receptor agonists, which work by stimulating insulin release and slowing digestion to control glucose spikes after meals.

    Original price was: $360.00.Current price is: $320.00.
    Add to cart
  • ZEPBOUND
    ,

    Zepbound

    Zepbound is the brand name for tirzepatide, a once‑weekly injectable medication approved by the U.S. Food and Drug Administration for chronic weight management in adults with obesity or adults with overweight who have at least one weight‑related condition.

    Price range: $290.00 through $750.00
    Select options This product has multiple variants. The options may be chosen on the product page
  • Sale! Bydureon BCise
    ,

    Bydureon Bcise

    Bydureon BCise is a once‑weekly, single‑dose autoinjector of extended‑release exenatide for adults with type 2 diabetes; the recommended dose is 2 mg subcutaneously once weekly, and it carries a boxed warning about thyroid C‑cell tumors and contraindications for patients with a personal or family history of medullary thyroid carcinoma or MEN 2.

    Original price was: $1,100.00.Current price is: $965.00.
    Add to cart